Skip to main content

Table 5 Logistic regression for the development of AKI

From: Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients

Dependent: AKI

 

OR (multivariable)

Age

 

1.00 (0.99–1.02, p = 0.794)

Sex

M

1.65 (1.11–2.49, p = 0.015)

Ethnicity

Asian

0.69 (0.31–1.42, p = 0.335)

Black

1.33 (0.70–2.45, p = 0.362)

Mixed

0.47 (0.02–3.15, p = 0.512)

Other

0.33 (0.02–1.76, p = 0.294)

Unknown

1.14 (0.42–2.76, p = 0.775)

Anticoagulation

 

1.02 (0.60–1.68, p = 0.952)

Hypertension

 

1.61 (1.07–2.46, p = 0.024)

Diabetes with complications

 

2.27 (0.93–5.40, p = 0.065)

Renal disease

 

2.31 (1.42–3.72, p = 0.001)

Cancer

 

1.57 (0.77–3.11, p = 0.203)

Metastatic cancer

 

1.45 (0.44–4.31, p = 0.522)

Day zeroa

Sodium

1.04 (1.01–1.07, p = 0.015)

CRP

1.00 (1.00–1.01, p = 0.003)

EWS

 

1.11 (1.00–1.23, p = 0.046)

  1. Number in dataframe = 1032, Number in model = 785, Missing = 247, AIC = 709.2, C-statistic = 0.708, H&L = Chi-sq(8) 4.76 (p = 0.783)
  2. Multivariable models adjusted by demographics and variables showing significance at univariable analysis (Univariate analysis is found in Supplementary Table 1)